secwatch.observer — SEC 8-K summary
======================================

Issuer:     Orgenesis Inc. (—)
CIK:        0001460602
Form:       8-K
Filed at:   2025-03-06T23:59:59+00:00
Accession:  0001493152-25-009380
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 2.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Orgenesis acquires spinal cord injury IP assets from Neurocords for 1.2M shares
-------------------------------------------------------------------------------

- Acquired IP assets for advanced regenerative therapies for spinal cord injuries from Neurocords, LLC.
- Issued 1,200,000 shares of common stock as consideration; shares restricted for 6 months then free-trading.
- Transaction closed March 3, 2025; prior licensing agreements terminated and mutual releases executed.
- Orgenesis also gets a 3-month option to acquire Rice University option agreement at no additional cost.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1460602/000149315225009380/0001493152-25-009380-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1460602/000149315225009380/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-009380

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer